A Moreau
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Genetics top 5%
- Inflammatory Bowel Disease
Papers in
- Oncology 22
- Drug Transport and Resistance Mechanisms 20
- Pharmacology 13
- Pharmacogenetics and Drug Metabolism 10
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Stéphane Paul (9 shared papers)Xavier Roblin (8 shared papers)Émilie Del Tedesco (6 shared papers)Christian Genin (8 shared papers)Jean‐Marc Pascussi (7 shared papers)Laurent Peyrin‐Biroulet (4 shared papers)Patrick Maurel (5 shared papers)Jean–Marc Phelip (4 shared papers)
- Journals
- Hepatology (4 papers)Inflammatory Bowel Diseases (3 papers)European Journal of Pharmaceutical Sciences (3 papers)Pharmaceutics (1 paper)PLoS ONE (1 paper)
- Partner nations
- FranceSwitzerlandCanada
In The Last Decade
A Moreau
53 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Pharmacology 199
- Genetics 569
- Oncology 272
- Epidemiology 303
- Hepatology 64
Countries citing papers authored by A Moreau
This map shows the geographic impact of A Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Moreau more than expected).
Fields of papers citing papers by A Moreau
This network shows the impact of papers produced by A Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Moreau. The network helps show where A Moreau may publish in the future.
Co-authors
The 25 scholars most cited alongside A Moreau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 228 | |
| 2 | 2013 | 184 | |
| 3 | 2007 | 184 | |
| 4 | 2014 | 89 | |
| 5 | 2009 | 83 | |
| 6 | 2014 | 70 | |
| 7 | 2011 | 54 | |
| 8 | 2017 | 38 | |
| 9 | 2009 | 37 | |
| 10 | 2017 | 36 | |
| 11 | 2009 | 35 | |
| 12 | 2010 | 34 | |
| 13 | 2007 | 31 | |
| 14 | 2010 | 31 | |
| 15 | 2015 | 30 | |
| 16 | 2022 | 29 | |
| 17 | 2007 | 22 | |
| 18 | 2018 | 22 | |
| 19 | 1994 | 20 | |
| 20 | 2013 | 17 |
About A Moreau
A Moreau is a scholar working on Oncology, Pharmacology, Pediatrics, Perinatology and Child Health, Molecular Biology and Infectious Diseases, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (20 papers), Pharmacogenetics and Drug Metabolism (10 papers), Pharmacological Effects and Toxicity Studies (10 papers), HIV/AIDS drug development and treatment (5 papers), Hormonal Regulation and Hypertension (4 papers), Inflammatory Bowel Disease (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Pharmacology (199 citations), Genetics (569 citations), Oncology (272 citations), Epidemiology (303 citations) and Hepatology (64 citations). A Moreau has collaborated with scholars based in France, Switzerland and Canada. Frequent co-authors include Stéphane Paul, Xavier Roblin, Émilie Del Tedesco, Christian Genin, Jean‐Marc Pascussi, Laurent Peyrin‐Biroulet, Patrick Maurel, Jean–Marc Phelip, Olivier Fardel and Marie José Vilarem. Their work appears in journals such as Hepatology, Inflammatory Bowel Diseases, European Journal of Pharmaceutical Sciences, Pharmaceutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.